The present invention is concerned with novel indol-3-yl-carbonyl-azaspiropiperidine derivatives as V1a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use for the treatment of anxiety and depressive disorders and other diseases. In particular, the present invention is concerned with compounds of the general formula (I)
wherein R
1
to R
6
, U, V, W, X, Y and Z are as defined in the specification.
本发明涉及新型
吲哚-3-基-羰基-氮杂螺环
哌啶衍
生物作为V1a受体拮抗剂,其制备方法,含有它们的药物组合物以及它们用于治疗焦虑和抑郁症等疾病的用途。具体而言,本发明涉及一般式(I)的化合物,其中R1至R6、U、V、W、X、Y和Z如规范中定义。